Testing effectiveness (Phase 2)Looking for participantsNCT07450547
What this trial is testing
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)
Anagram Therapeutics, Inc. 113